Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1687-8329
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease ; volume:56 ; number:1 ; day:13 ; month:2 ; year:2020 ; pages:1-6 ; date:12.2020
The Egyptian journal of neurology, psychiatry and neurosurgery ; 56, Heft 1 (13.2.2020), 1-6, 12.2020
- Urheber
-
Shaheen, Hala
Sobhy, Sayed
El Mously, Sherine
Abuomira, Marwa
Mansour, Mohamed
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41983-020-0159-7
- URN
-
urn:nbn:de:101:1-2020051123231007161852
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shaheen, Hala
- Sobhy, Sayed
- El Mously, Sherine
- Abuomira, Marwa
- Mansour, Mohamed
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Nanoplastic Stimulates the Amyloidogenesis of Parkinson's Alpha‐Synuclein NACore
Endonuclease G mediates [alpha]-synuclein cytotoxicity during Parkinson's disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance